Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Cutaneous Ulcers With a Novel Biological Dressing

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00207818
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : February 11, 2014
Sponsor:
Information provided by (Responsible Party):
CHU de Quebec-Universite Laval

Brief Summary:
The aim of the study is to evaluate the effect of a biological dressing on the healing process of venous ulcers. The dressing is a reconstructed skin substitute made with the patients own cells.

Condition or disease Intervention/treatment Phase
Venous Ulcers Device: self assembled skin substitute (SASS) Phase 1 Phase 2

Detailed Description:
The hypothesis of this trial is that the cutaneous model SASS, a dermal epidermal skin substitute, created by the LOEX could be as high-performant, or even better, than the one's already existent in North America for the wound care. We anticipate showing on 6 patients that ulcer that did not close with conventional treatment, will heal or at least improve with this treatment.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 6 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Treatment of Cutaneous Ulcers With a Novel Biological Dressing
Study Start Date : September 1999
Actual Primary Completion Date : June 2009
Actual Study Completion Date : June 2009

Intervention Details:
  • Device: self assembled skin substitute (SASS)
    Wound care with self assembled skin substitute (SASS)


Primary Outcome Measures :
  1. wound closure

Secondary Outcome Measures :
  1. % of healing at 6 months of treatment


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Men or women from 18 to 85 years old
  2. Have a venous ulcer or a mixed ulcer

Exclusion Criteria:

Diabetes Mental deficiency Hepatitis holder (A-B-C) HIV positive Pregnancy or lactation Corticosteroids therapy Radiotherapy Chemotherapy


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00207818


Locations
Layout table for location information
Canada
Centre hospitalier affilie universitaire de Quebec
Quebec, Canada, G1J 1Z4
Sponsors and Collaborators
CHU de Quebec-Universite Laval
Investigators
Layout table for investigator information
Principal Investigator: Francois A Auger, MD Centre hospitalier affilié universitaire de Québec
Study Director: Lucie Germain, Ph.D. Centre hospitalier affilié universitaire de Québec
Additional Information:
Publications:
Layout table for additonal information
Responsible Party: CHU de Quebec-Universite Laval
ClinicalTrials.gov Identifier: NCT00207818    
Other Study ID Numbers: LOEX 005
29478 Health Canada
First Posted: September 21, 2005    Key Record Dates
Last Update Posted: February 11, 2014
Last Verified: February 2014
Keywords provided by CHU de Quebec-Universite Laval:
tissue engineered wound dressing; autologous skin substitute; biological dressing; wound care
Additional relevant MeSH terms:
Layout table for MeSH terms
Varicose Ulcer
Skin Ulcer
Ulcer
Pathologic Processes
Varicose Veins
Vascular Diseases
Cardiovascular Diseases
Leg Ulcer
Skin Diseases